Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 172

1.

Cephalosporin nitric oxide-donor prodrug DEA-C3D disperses biofilms formed by clinical cystic fibrosis isolates of Pseudomonas aeruginosa.

Soren O, Rineh A, Silva DG, Cai Y, Howlin RP, Allan RN, Feelisch M, Davies JC, Connett GJ, Faust SN, Kelso MJ, Webb JS.

J Antimicrob Chemother. 2020 Jan 1;75(1):117-125. doi: 10.1093/jac/dkz378.

2.

Evaluation of a Bioengineered Honey and Its Synthetic Equivalent as Novel Staphylococcus aureus Biofilm-Targeted Topical Therapies in Chronic Rhinosinusitis.

Papadopoulou D, Dabrowska A, Harries PG, Webb JS, Allan RN, Salib RJ.

Am J Rhinol Allergy. 2020 Jan;34(1):80-86. doi: 10.1177/1945892419874700. Epub 2019 Sep 11. No abstract available.

PMID:
31510757
3.

Immunological profiling of key inflammatory drivers of nasal polyp formation and growth in chronic rhinosinusitis.

Biggs TC, Hayes SM, Harries PG, Allan RN, Walls AF, Pender SLF, Salib RJ.

Rhinology. 2019 Oct 1;57(5):336-342. doi: 10.4193/Rhin19.167.

PMID:
31317972
4.

Staphylococcus aureus internalization in mast cells in nasal polyps: Characterization of interactions and potential mechanisms.

Hayes SM, Biggs TC, Goldie SP, Harries PG, Walls AF, Allan RN, Pender SLF, Salib RJ.

J Allergy Clin Immunol. 2020 Jan;145(1):147-159. doi: 10.1016/j.jaci.2019.06.013. Epub 2019 Jun 27.

PMID:
31254531
5.

Antimicrobial activity of a novel bioengineered honey against non-typeable Haemophilus influenzae biofilms: an in vitro study.

Newby RS, Dryden M, Allan RN, Salib RJ.

J Clin Pathol. 2018 Jun;71(6):554-558. doi: 10.1136/jclinpath-2017-204901. Epub 2018 Feb 15.

PMID:
29449345
6.

Targeting microbial biofilms: current and prospective therapeutic strategies.

Koo H, Allan RN, Howlin RP, Stoodley P, Hall-Stoodley L.

Nat Rev Microbiol. 2017 Dec;15(12):740-755. doi: 10.1038/nrmicro.2017.99. Epub 2017 Sep 25. Review.

7.

Primary ciliary dyskinesia ciliated airway cells show increased susceptibility to Haemophilus influenzae biofilm formation.

Walker WT, Jackson CL, Allan RN, Collins SA, Kelso MJ, Rineh A, Yepuri NR, Nicholas B, Lau L, Johnston D, Lackie P, Faust SN, Lucas JSA, Hall-Stoodley L.

Eur Respir J. 2017 Sep 10;50(3). pii: 1700612. doi: 10.1183/13993003.00612-2017. Print 2017 Sep.

8.

Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.

Howlin RP, Cathie K, Hall-Stoodley L, Cornelius V, Duignan C, Allan RN, Fernandez BO, Barraud N, Bruce KD, Jefferies J, Kelso M, Kjelleberg S, Rice SA, Rogers GB, Pink S, Smith C, Sukhtankar PS, Salib R, Legg J, Carroll M, Daniels T, Feelisch M, Stoodley P, Clarke SC, Connett G, Faust SN, Webb JS.

Mol Ther. 2017 Sep 6;25(9):2104-2116. doi: 10.1016/j.ymthe.2017.06.021. Epub 2017 Jul 24.

9.

D-methionine interferes with non-typeable Haemophilus influenzae peptidoglycan synthesis during growth and biofilm formation.

Dawe H, Berger E, Sihlbom C, Angus EM, Howlin RP, Laver JR, Tebruegge M, Hall-Stoodley L, Stoodley P, Faust SN, Allan RN.

Microbiology. 2017 Jul;163(7):1093-1104. doi: 10.1099/mic.0.000491. Epub 2017 Jul 21.

PMID:
28699879
10.

Cephalosporin-NO-donor prodrug PYRRO-C3D shows β-lactam-mediated activity against Streptococcus pneumoniae biofilms.

Allan RN, Kelso MJ, Rineh A, Yepuri NR, Feelisch M, Soren O, Brito-Mutunayagam S, Salib RJ, Stoodley P, Clarke SC, Webb JS, Hall-Stoodley L, Faust SN.

Nitric Oxide. 2017 May 1;65:43-49. doi: 10.1016/j.niox.2017.02.006. Epub 2017 Feb 21.

PMID:
28235635
11.

Reactive oxygen: A novel antimicrobial mechanism for targeting biofilm-associated infection.

Dryden MS, Cooke J, Salib RJ, Holding RE, Biggs T, Salamat AA, Allan RN, Newby RS, Halstead F, Oppenheim B, Hall T, Cox SC, Grover LM, Al-Hindi Z, Novak-Frazer L, Richardson MD.

J Glob Antimicrob Resist. 2017 Mar;8:186-191. doi: 10.1016/j.jgar.2016.12.006. Epub 2017 Feb 14. Review.

PMID:
28213334
12.

Corticosteroids and infliximab impair the performance of interferon-γ release assays used for diagnosis of latent tuberculosis.

Edwards A, Gao Y, Allan RN, Ball D, de Graaf H, Coelho T, Clifford V, Curtis N, Williams A, Faust SN, Mansour S, Marshall B, Elkington P, Tebruegge M.

Thorax. 2017 Oct;72(10):946-949. doi: 10.1136/thoraxjnl-2016-209397. Epub 2017 Feb 3.

PMID:
28159773
13.

Cephalosporin-3'-Diazeniumdiolate NO Donor Prodrug PYRRO-C3D Enhances Azithromycin Susceptibility of Nontypeable Haemophilus influenzae Biofilms.

Collins SA, Kelso MJ, Rineh A, Yepuri NR, Coles J, Jackson CL, Halladay GD, Walker WT, Webb JS, Hall-Stoodley L, Connett GJ, Feelisch M, Faust SN, Lucas JS, Allan RN.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e02086-16. doi: 10.1128/AAC.02086-16. Print 2017 Feb.

14.

Parallel Evolution in Streptococcus pneumoniae Biofilms.

Churton NW, Misra RV, Howlin RP, Allan RN, Jefferies J, Faust SN, Gharbia SE, Edwards RJ, Clarke SC, Webb JS.

Genome Biol Evol. 2016 May 9;8(5):1316-26. doi: 10.1093/gbe/evw072.

15.

Low Concentrations of Nitric Oxide Modulate Streptococcus pneumoniae Biofilm Metabolism and Antibiotic Tolerance.

Allan RN, Morgan S, Brito-Mutunayagam S, Skipp P, Feelisch M, Hayes SM, Hellier W, Clarke SC, Stoodley P, Burgess A, Ismail-Koch H, Salib RJ, Webb JS, Faust SN, Hall-Stoodley L.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2456-66. doi: 10.1128/AAC.02432-15. Print 2016 Apr.

16.

Environmental temperature impacts on the performance of QuantiFERON-TB Gold In-Tube assays.

Jarvis J, Gao Y, de Graaf H, Hughes S, Allan RN, Williams A, Marshall B, Elkington P, Faust SN, Tebruegge M.

J Infect. 2015 Aug;71(2):276-80. doi: 10.1016/j.jinf.2015.04.004. Epub 2015 Apr 11. No abstract available.

PMID:
25869537
17.

Invasive Propionibacterium acnes infections in a non-selective patient cohort: clinical manifestations, management and outcome.

Tebruegge M, Jones C, de Graaf H, Sukhtankar P, Allan RN, Howlin RP, Browning D, Schuster H, Pallett A, Patel S, Faust SN.

Eur J Clin Microbiol Infect Dis. 2015 Mar;34(3):527-34. doi: 10.1007/s10096-014-2256-y. Epub 2014 Oct 18.

PMID:
25326276
18.

New approaches to the treatment of biofilm-related infections.

Wilkins M, Hall-Stoodley L, Allan RN, Faust SN.

J Infect. 2014 Nov;69 Suppl 1:S47-52. doi: 10.1016/j.jinf.2014.07.014. Epub 2014 Sep 17. Review.

PMID:
25240819
19.

Pronounced metabolic changes in adaptation to biofilm growth by Streptococcus pneumoniae.

Allan RN, Skipp P, Jefferies J, Clarke SC, Faust SN, Hall-Stoodley L, Webb J.

PLoS One. 2014 Sep 4;9(9):e107015. doi: 10.1371/journal.pone.0107015. eCollection 2014.

20.

Effect of amino acid substitutions in the GerAA protein on the function of the alanine-responsive germinant receptor of Bacillus subtilis spores.

Mongkolthanaruk W, Cooper GR, Mawer JS, Allan RN, Moir A.

J Bacteriol. 2011 May;193(9):2268-75. doi: 10.1128/JB.01398-10. Epub 2011 Mar 4.

21.

Brevibacillus levickii sp. nov. and Aneurinibacillus terranovensis sp. nov., two novel thermoacidophiles isolated from geothermal soils of northern Victoria Land, Antarctica.

Allan RN, Lebbe L, Heyrman J, De Vos P, Buchanan CJ, Logan NA.

Int J Syst Evol Microbiol. 2005 May;55(Pt 3):1039-50.

PMID:
15879231
22.

Crohn's disease patients who quit smoking have a reduced risk of reoperation for recurrence.

Ryan WR, Allan RN, Yamamoto T, Keighley MR.

Am J Surg. 2004 Feb;187(2):219-25.

PMID:
14769308
23.

Mistaken identity: misclassification of TPMT phenotype following blood transfusion.

Cheung ST, Allan RN.

Eur J Gastroenterol Hepatol. 2003 Nov;15(11):1245-7.

PMID:
14560161
24.

Patients with Crohn's disease are unaware of the risks that smoking has on their disease.

Ryan WR, Ley C, Allan RN, Keighley MR.

J Gastrointest Surg. 2003 Jul-Aug;7(5):706-11.

PMID:
12850686
25.

How does pouch construction for a final diagnosis of Crohn's disease compare with ileoproctostomy for established Crohn's proctocolitis?

Mylonakis E, Allan RN, Keighley MR.

Dis Colon Rectum. 2001 Aug;44(8):1137-42; discussion 1142-3.

PMID:
11535853
26.

Long-term outcome of surgical management for diffuse jejunoileal Crohn's disease.

Yamamoto T, Allan RN, Keighley MR.

Surgery. 2001 Jan;129(1):96-102.

PMID:
11150039
27.

Effect of fecal diversion alone on perianal Crohn's disease.

Yamamoto T, Allan RN, Keighley MR.

World J Surg. 2000 Oct;24(10):1258-62; discussion 1262-3.

PMID:
11071472
28.

Risk factors for intra-abdominal sepsis after surgery in Crohn's disease.

Yamamoto T, Allan RN, Keighley MR.

Dis Colon Rectum. 2000 Aug;43(8):1141-5.

PMID:
10950014
29.

Ileal pouch-anal anastomosis for Crohn's disease.

Keighley MR, Allan RN, Sanders DS.

Gut. 1999 Mar;44(3):440-1. No abstract available.

30.

Audit of single-stage proctocolectomy for Crohn's disease: postoperative complications and recurrence.

Yamamoto T, Allan RN, Keighley MR.

Dis Colon Rectum. 2000 Feb;43(2):249-56.

PMID:
10696900
31.

Escherichia coli for ulcerative colitis.

Langman MJ, Allan RN.

Lancet. 1999 Dec 4;354(9194):2000-1. No abstract available.

PMID:
10622327
32.

An audit of gastroduodenal Crohn disease: clinicopathologic features and management.

Yamamoto T, Allan RN, Keighley MR.

Scand J Gastroenterol. 1999 Oct;34(10):1019-24.

PMID:
10563673
33.

Strategy for surgical management of ileocolonic anastomotic recurrence in Crohn's disease.

Yamamoto T, Allan RN, Keighley MR.

World J Surg. 1999 Oct;23(10):1055-60; discussion 1060-1.

PMID:
10512947
34.

Stapled functional end-to-end anastomosis versus sutured end-to-end anastomosis after ileocolonic resection in Crohn disease.

Yamamoto T, Bain IM, Mylonakis E, Allan RN, Keighley MR.

Scand J Gastroenterol. 1999 Jul;34(7):708-13.

PMID:
10466883
35.

Smoking is a predictive factor for outcome after colectomy and ileorectal anastomosis in patients with Crohn's colitis.

Yamamoto T, Allan RN, Keighley MR.

Br J Surg. 1999 Aug;86(8):1069-70. No abstract available.

PMID:
10460646
36.

An audit of strictureplasty for small-bowel Crohn's disease.

Yamamoto T, Bain IM, Allan RN, Keighley MR.

Dis Colon Rectum. 1999 Jun;42(6):797-803.

PMID:
10378605
37.

Coeliac disease and disseminated lymphomatosis.

Kulshrestha MK, Honan WP, Aluwihare N, Carey M, Allan RN.

J R Soc Med. 1998 Nov;91(11):594-6. No abstract available.

38.
39.

Persistent perineal sinus after proctocolectomy for Crohn's disease.

Yamamoto T, Bain IM, Allan RN, Keighley MR.

Dis Colon Rectum. 1999 Jan;42(1):96-101.

PMID:
10211527
40.

Ischaemic enterocolitis complicating idiopathic dysautonomia.

Woodward JM, Sanders DS, Keighley MR, Allan RN.

Gut. 1998 Aug;43(2):285-7.

41.

Outcome of strictureplasty for duodenal Crohn's disease.

Yamamoto T, Bain IM, Connolly AB, Allan RN, Keighley MR.

Br J Surg. 1999 Feb;86(2):259-62.

PMID:
10100799
42.

Metabolic problems in inflammatory bowel disease.

Allan RN.

Neth J Med. 1998 Dec;53(6):S9-12. Review. No abstract available.

PMID:
9883008
43.

A simple clinical colitis activity index.

Walmsley RS, Ayres RC, Pounder RE, Allan RN.

Gut. 1998 Jul;43(1):29-32.

44.

Prognosis and management of Crohn's disease in the over-55 age group.

Walmsley RS, Gillen CD, Allan RN.

Postgrad Med J. 1997 Apr;73(858):225-9.

45.

Progression of ulcerative proctosigmoiditis: incidence and factors influencing progression.

Ayres RC, Gillen CD, Walmsley RS, Allan RN.

Eur J Gastroenterol Hepatol. 1996 Jun;8(6):555-8.

PMID:
8823569
46.

Bilateral endogenous Escherichia coli endophthalmitis: a devastating complication in an insulin-dependent diabetic.

Walmsley RS, David DB, Allan RN, Kirkby GR.

Postgrad Med J. 1996 Jun;72(848):361-3. Review.

47.

Antibodies against Mycobacterium paratuberculosis in Crohn's disease.

Walmsley RS, Ibbotson JP, Chahal H, Allan RN.

QJM. 1996 Mar;89(3):217-21.

PMID:
8731566
48.

A national training programme for gastroenterology and hepatology.

Farthing MJ, Walt RP, Allan RN, Swan CH, Gilmore IT, Mallinson CN, Bennett JR, Hawkey CJ, Burnham WR, Morris AI, Tibbs CJ, Bowling TE, Cobb C, Catnach S, Farrell C, Towle A.

Gut. 1996 Mar;38(3):459-70. No abstract available.

49.

Occult small bowel adenocarcinoma complicating Crohn's disease: a report of three cases.

Gillen CD, Wilson CA, Walmsley RS, Sanders DS, O'Dwyer ST, Allan RN.

Postgrad Med J. 1995 Mar;71(833):172-4.

50.

Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis.

Gillen CD, Walmsley RS, Prior P, Andrews HA, Allan RN.

Gut. 1994 Nov;35(11):1590-2.

Supplemental Content

Loading ...
Support Center